![](/img/cover-not-exists.png)
A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer
Stacy L. Moulder, Frankie A. Holmes, Anthony W. Tolcher, Peter Thall, Kristine Broglio, Vicente Valero, Aman U. Buzdar, Susan G. Arbuck, Andrew Seidman, Gabriel N. HortobagyiVolume:
116
Year:
2010
Language:
english
Pages:
8
DOI:
10.1002/cncr.24870
File:
PDF, 168 KB
english, 2010